384 related articles for article (PubMed ID: 2453340)
21. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
23. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
[TBL] [Abstract][Full Text] [Related]
24. Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats.
Zumsteg U; Reimers JI; Pociot F; Mørch L; Helqvist S; Brendel M; Alejandro R; Mandrup-Poulsen T; Dinarello CA; Nerup J
Diabetologia; 1993 Aug; 36(8):759-66. PubMed ID: 8405744
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.
Comens PG; Wolf BA; Unanue ER; Lacy PE; McDaniel ML
Diabetes; 1987 Aug; 36(8):963-70. PubMed ID: 3297891
[TBL] [Abstract][Full Text] [Related]
26. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
27. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
28. Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets.
Akesson B; Panagiotidis G; Westermark P; Lundquist I
Regul Pept; 2003 Mar; 111(1-3):55-60. PubMed ID: 12609749
[TBL] [Abstract][Full Text] [Related]
29. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.
Verchere CB; D'Alessio DA; Prigeon RL; Hull RL; Kahn SE
Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831
[TBL] [Abstract][Full Text] [Related]
30. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
Patel YC; Pierzchala I; Amherdt M; Orci L
J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
[TBL] [Abstract][Full Text] [Related]
31. [Impact of islet alpha cell loss on insulin secretion].
Li G; Ye L; Li J; Yang W; Lou J
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1427-31. PubMed ID: 12509929
[TBL] [Abstract][Full Text] [Related]
32. Effect of low concentrations of glucagon on insulin release and cyclic AMP content in isolated rat islets.
Siegel EG; Creutzfeldt W
Metabolism; 1987 Oct; 36(10):953-7. PubMed ID: 2443791
[TBL] [Abstract][Full Text] [Related]
33. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
Mandrup-Poulsen T; Bendtzen K; Dinarello CA; Nerup J
J Immunol; 1987 Dec; 139(12):4077-82. PubMed ID: 3320203
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1.
Sandler S; Welsh N
Biochem Biophys Res Commun; 1993 Sep; 195(2):859-65. PubMed ID: 8373422
[TBL] [Abstract][Full Text] [Related]
35. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
Reimers JI; Andersen HU; Mauricio D; Pociot F; Karlsen AE; Petersen JS; Mandrup-Poulsen T; Nerup J
Diabetes; 1996 Jun; 45(6):771-8. PubMed ID: 8635652
[TBL] [Abstract][Full Text] [Related]
36. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.
Kahn SE; D'Alessio DA; Schwartz MW; Fujimoto WY; Ensinck JW; Taborsky GJ; Porte D
Diabetes; 1990 May; 39(5):634-8. PubMed ID: 2185112
[TBL] [Abstract][Full Text] [Related]
37. Decreased glucose-induced cAMP and insulin release in islets of diabetic rats: reversal by IBMX, glucagon, GIP.
Dachicourt N; Serradas P; Giroix MH; Gangnerau MN; Portha B
Am J Physiol; 1996 Oct; 271(4 Pt 1):E725-32. PubMed ID: 8897861
[TBL] [Abstract][Full Text] [Related]
38. Formation of islet cell monolayers from fetal human and neonatal rat pancreatic islets: protein biosynthesis, insulin secretion, and binding of islet cell antibodies.
Kohnert KD; Ziegler B; Dietz H; Hahn von Dorsche H; Ziegler M; Reiher H
Acta Biol Med Ger; 1982; 41(12):1163-70. PubMed ID: 6201030
[TBL] [Abstract][Full Text] [Related]
39. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
D'Alessio DA; Fujimoto WY; Ensinck JW
Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
[TBL] [Abstract][Full Text] [Related]
40. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
